Add BrightSurf on Google Email

Keck Medicine of USC treatment plan significantly reduces hospitalizations and deaths of liver and kidney transplant recipients with COVID-19

A new protocol combining patient monitoring and monoclonal antibody therapy reduced hospitalizations by half and deaths to zero for eligible patients. The study, conducted at Keck Medicine of USC, shows improved outcomes among liver and kidney transplant recipients with COVID-19.

SourceUniversity of Southern California - Health Sciences·JournalTransplantation·TypeObservational study·DateOct 14, 2021

Fewer patients sought treatment for kidney failure in early months of COVID-19 pandemic

A new study found that the COVID-19 pandemic led to a 30% decline in patients seeking treatment for kidney failure, with Black patients experiencing significantly worse kidney function. The decline was attributed to changes in healthcare delivery and may reflect delays in treatment due to fear of infection or logistical barriers.

SourceBrown University·JournalJAMA Network Open·TypeObservational study·DateOct 13, 2021

Details behind kidney transplant recipients’ immune response to the virus that causes COVID-19

Research provides insights on immune responses of kidney transplant recipients following SARS-CoV-2 infection. The study found that production of IgG antibodies against the virus was delayed in these individuals, but their IgM and IgA responses were similar to those observed in non-transplant individuals.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateOct 1, 2021

Researchers reveal pathogenesis and therapeutic strategy of pre-engraftment syndrome

Severe PES is characterized by high fever, rash, diarrhea, and increased transplant-related mortality. A study revealed that monocytes derived from cord blood produce proinflammatory cytokines, leading to PES. Tocilizumab treatment significantly controlled clinical symptoms and reduced mortality in patients with severe PES

SourceUniversity of Science and Technology of China·JournalNature Communications·DateJul 17, 2021

First trial of faecal microbiota transplantation for people with active peripheral psoriatic arthritis shows no advantage

A double-blind trial found that faecal microbiota transplantation did not improve treatment outcomes or reduce symptoms in patients with active peripheral PsA. The study suggests that FMT may not be an effective treatment option for this condition, and future research is needed to explore its potential benefits.

Many patients with high priority for kidney transplants not placed on transplant waitlist

A new study reveals that many patients with high-priority kidney transplants are not being placed on the transplant waiting list, despite having long expected post-transplant survival. African Americans, uninsured individuals, and those living in lower-income communities face significant barriers to expedited waitlist placement.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateJun 17, 2021

Heart transplants: Age is no barrier to successful surgery

A new study published in the Journal of the American Geriatrics Society found that heart transplant surgery has a similar mortality rate for adults aged 18-69 and 70+, with only minor differences in stroke risk and donor hearts. Advanced age alone should not prevent people from being considered as candidates for heart transplants.

SourceAmerican Geriatrics Society·JournalJournal of the American Geriatrics Society·DateJun 9, 2021

Waitlist policies may contribute to racial disparities in kidney transplant access

A recent study found that enrolling Black patients on the waitlist with slightly better kidney function could reduce racial disparities in transplant access. This approach aims to bridge the gap between Black and white patients' wait times before kidney failure, ultimately promoting greater equality in transplantation.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateFeb 23, 2021

Recent efforts haven't improved access to kidney transplantation

Despite policies and interventions aimed at improving access to kidney transplantation, a new study found no overall improvement in rates of wait list placement and transplantation over two decades. The researchers also identified striking disparities in access to transplantation, highlighting the need for more effective strategies to ...

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateFeb 11, 2021

When is dead really dead?

A new international study documents the physiology of dying and confirms that death is an irreversible process. The DePPaRT study found that cardiac activity often stops and restarts several times during the dying process, but no one regained sustained circulation or consciousness. This provides evidence to support the current standard...

SourceChildren's Hospital of Eastern Ontario Research Institute·JournalNew England Journal of Medicine·DateJan 27, 2021

Virtual kidney transplant evaluation allows patients to be evaluated from home

A virtual telehealth platform allows patients to undergo comprehensive evaluation for kidney transplantation from the comfort of their own homes. This innovative approach has enabled the Medical University of South Carolina's transplant program to maintain access to life-saving surgeries despite pandemic restrictions, with over 282 pat...

SourceAmerican College of Surgeons·JournalJournal of the American College of Surgeons·DateDec 21, 2020

UBCO researchers suggest stool transplants can battle serious infections

Researchers analyzed gut composition and DNA to identify key factors for successful fecal microbiota transplants, including the donor's microbiome and recipient's pre-transplant gut community structures. The study suggests that preparing donors' and patients' gut ecosystems prior to transplant may increase the likelihood of success.

SourceUniversity of British Columbia Okanagan campus·JournalScientific Reports·DateDec 9, 2020

Consuming your own fecal microbiome when dieting may limit weight regain -- Ben-Gurion University

A new study published in Gastroenterology found that consuming frozen microbiome capsules derived from their own feces when dieting may limit weight regain. Participants who followed a green-Mediterranean diet and received fecal microbiome transplantation lost more weight and regained less weight compared to those on other diets.

Survival on heart transplant waiting list

This observational study found that advanced treatment protocols significantly improved survival rates for heart transplant waiting list patients. Researchers examined data from over 11,000 patients and discovered a strong correlation between timely interventions and better outcomes.

SourceJAMA Network·JournalJAMA Cardiology·DateAug 12, 2020

New website offers added decision support for patients searching for a transplant center

A new online tool developed by Hennepin Healthcare Research Institute and the University of Minnesota helps transplant candidates find matching programs based on their donor type and medical profile. The website uses data from the Scientific Registry of Transplant Recipients (SRTR) to provide personalized decision support.

SourceHennepin Healthcare Research Institute·JournalTransplantation Direct·DateAug 5, 2020

COVID-19 in patients who have received kidney transplants or are undergoing dialysis

Two new studies investigate COVID-19 in kidney transplant recipients, finding most don't need hospitalization, and patients on dialysis may experience different symptoms. Additionally, another study reveals distinct clinical features of dialysis patients with COVID-19, highlighting the need for more research and guidance.

SourceAmerican Society of Nephrology·JournalClinical Journal of the American Society of Nephrology·DateJul 7, 2020